v3.26.1
Revenue
 6 Months Ended
Jun. 30, 2026
Revenue Recognition [Abstract]  
Revenue

3. Revenue

Net sales by geography are as follows (in millions):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

United States

 

$

1,239.9

 

 

$

1,173.8

 

 

$

2,449.3

 

 

$

2,287.4

 

International

 

 

937.0

 

 

 

903.5

 

 

 

1,814.4

 

 

 

1,699.0

 

Total

 

$

2,177.0

 

 

$

2,077.3

 

 

$

4,263.7

 

 

$

3,986.4

 

 

Net sales by product category are as follows (in millions):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Knees

 

$

828.9

 

 

$

826.0

 

 

$

1,657.5

 

 

$

1,618.9

 

Hips

 

 

562.7

 

 

 

536.1

 

 

 

1,086.8

 

 

 

1,031.9

 

S.E.T.

 

 

586.0

 

 

 

550.6

 

 

 

1,148.2

 

 

 

1,021.1

 

Technology & Data, Bone Cement and Surgical

 

 

199.4

 

 

 

164.6

 

 

 

371.2

 

 

 

314.5

 

Total

 

$

2,177.0

 

 

$

2,077.3

 

 

$

4,263.7

 

 

$

3,986.4

 

 

S.E.T. includes sales from our Sports Medicine, Upper Extremities, Foot and Ankle, Trauma, Craniomaxillofacial and Thoracic ("CMFT") product categories.

 

This net sales presentation differs from our reportable operating segments, which are based upon our senior management organizational structure and how we allocate resources toward achieving operating profit goals. Each of our reportable operating segments sells all the product categories noted above. Accordingly, the only difference from the presentation above and our reportable operating segments are the geographic groupings.